Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

33%

2 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 1
3(50.0%)
Phase 3
2(33.3%)
Phase 2
1(16.7%)
6Total
Phase 1(3)
Phase 3(2)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07239414Phase 3Not Yet Recruiting

Bempedoic Acid Versus Statins in Primary-Prevention Patients With Suboptimal Statin Adherence: Effects on LDL-C Reduction and Tolerability

Role: lead

NCT04473261Phase 1Unknown

Efficacy of Iodine Complex Against COVID-19 Patients

Role: lead

NCT04767087Phase 2Unknown

Honey and Nigella Sativa in COVID-19 Prophylaxis

Role: lead

NCT04472585Phase 1Unknown

Efficacy of Subcutaneous Ivermectin With or Without Zinc in COVID-19 Patients

Role: lead

NCT04715269Phase 1Unknown

Role of Alprazolam in the Management of Acute Coronary Syndrome

Role: lead

NCT04347382Phase 3Completed

Honey & Nigella Sativa Trial Against COVID-19

Role: lead

All 6 trials loaded